Recent Advances in Cardiovascular Diagnostic Techniques

Author(s):  
Robert B. Case
2000 ◽  
Vol 56 (2) ◽  
pp. 143-148
Author(s):  
PK MENON ◽  
K KAPILA ◽  
VC OHRI

2015 ◽  
Vol 4 (2) ◽  
Author(s):  
Chi Lok Wong ◽  
U.S. Dinish ◽  
Malini Olivo

AbstractPersonalized medicine is revolutionizing modern health care. The aim of personalized diagnostics is to provide rapid, portable and simple tests that will reduce diagnosis time. They enable rapid analysis performed near the patient and provide specific details of the patient’s condition so that a personalized treatment can be made. This review focuses on the recent advances in optical diagnostic techniques based on surface plasmon resonance (SPR) and surface-enhanced Raman scattering spectroscopy (SERS) for translational medical diagnostics. In the first part, recent developments in SPR biosensors for infectious disease diagnosis are presented including the first two-dimensional multiplex influenza SPR biosensor for H1N1 (influenza A) and H3N2 (seasonal influenza) detection. In the second part, advances in SERS, which is another ultra-sensitive optical diagnostic technique for various cancer detection applications in pre-clinical and clinical settings, are reviewed.


2021 ◽  
Vol Volume 12 ◽  
pp. 181-196
Author(s):  
Sumeeta Khurana ◽  
Shreya Singh ◽  
Abhishek Mewara

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Qiang Sun ◽  
Gerry Melino ◽  
Ivano Amelio ◽  
Jingting Jiang ◽  
Ying Wang ◽  
...  

AbstractCancer immunotherapy represents a major advance in the cure of cancer following the dramatic advancements in the development and refinement of chemotherapies and radiotherapies. In the recent decades, together with the development of early diagnostic techniques, immunotherapy has significantly contributed to improving the survival of cancer patients. The immune-checkpoint blockade agents have been proven effective in a significant fraction of standard therapy refractory patients. Importantly, recent advances are providing alternative immunotherapeutic tools that could help overcome their limitations. In this mini review, we provide an overview on the main steps of the discovery of classic immune-checkpoint blockade agents and summarise the most recent development of novel immunotherapeutic strategies, such as tumour antigens, bispecific antibodies and TCR-engineered T cells.


Sign in / Sign up

Export Citation Format

Share Document